Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Agios Pharmaceuticals Q3 EPS $(1.78) Beats $(1.91) Estimate, Sales $12.880M Beat $10.417M Estimate

Author: Benzinga Newsdesk | October 30, 2025 05:35am
Agios Pharmaceuticals (NASDAQ:AGIO) reported quarterly losses of $(1.78) per share which beat the analyst consensus estimate of $(1.91) by 7 percent. This is a 110.97 percent decrease over earnings of $16.22 per share from the same period last year. The company reported quarterly sales of $12.880 million which beat the analyst consensus estimate of $10.417 million by 23.64 percent. This is a 43.69 percent increase over sales of $8.964 million the same period last year.

Posted In: AGIO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist